Publikationen, an denen er mitarbeitet Luis Francisco Lorenzo Martín (27)

2024

  1. VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors

    Oncogene, Vol. 42, Núm. 5, pp. 389-405

  2. The Rho GTPase exchange factor Vav2 promotes extensive age-dependent rewiring of the hair follicle stem cell transcriptome

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors

    Cell Reports, Vol. 38, Núm. 11

  2. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model

    Molecular Oncology, Vol. 16, Núm. 19, pp. 3533-3553

  3. CiberAMP: An R Package to Identify Differential mRNA Expression Linked to Somatic Copy Number Variations in Cancer Datasets

    Biology, Vol. 11, Núm. 10

  4. The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function

    Oncogene, Vol. 41, Núm. 24, pp. 3341-3354

2021

  1. Aryl hydrocarbon receptor controls skin homeostasis, regeneration, and hair follicle cycling by adjusting epidermal stem cell function

    Stem Cells, Vol. 39, Núm. 12, pp. 1733-1750

  2. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis

    EMBO Journal, Vol. 40, Núm. 22

  3. New functions of vav family proteins in cardiovascular biology, skeletal muscle, and the nervous system

    Biology, Vol. 10, Núm. 9

2020

  1. Computational and in vitro Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity

    Frontiers in Cell and Developmental Biology, Vol. 8

  2. Drug vulnerabilities and disease prognosis linked to the stem cell-like gene expression program triggered by the RHO GTPase activator VAV2 in hyperplastic keratinocytes and head and neck cancer

    Cancers, Vol. 12, Núm. 9, pp. 1-14

  3. Herc ubiquitin ligases in cancer

    Cancers, Vol. 12, Núm. 6, pp. 1-13

  4. In Silico Analysis of the Age-Dependent Evolution of the Transcriptome of Mouse Skin Stem Cells

    Cells, Vol. 9, Núm. 1

  5. Lysine Acetylation Reshapes the Downstream Signaling Landscape of Vav1 in Lymphocytes

    Cells, Vol. 9, Núm. 3

  6. Rho guanosine nucleotide exchange factors are not such bad guys after all in cancera

    Small GTPases, Vol. 11, Núm. 4, pp. 233-239

  7. VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma

    Nature Communications, Vol. 11, Núm. 1

  8. Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis

    Nature Communications, Vol. 11, Núm. 1

  9. Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor

    Oncogene, Vol. 39, Núm. 28, pp. 5098-5111

2019

  1. Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output

    Cells, Vol. 8, Núm. 12